Anti-LOXL2 antibody [7HCLC] (ab277807)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit recombinant multiclonal [7HCLC] to LOXL2
- Suitable for: ICC, WB
- Reacts with: Human
Overview
-
Product name
Anti-LOXL2 antibody [7HCLC]
See all LOXL2 primary antibodies -
Description
Rabbit recombinant multiclonal [7HCLC] to LOXL2 -
Host species
Rabbit -
Tested applications
Suitable for: ICC, WBmore details -
Species reactivity
Reacts with: Human -
Immunogen
Synthetic peptide corresponding to Human LOXL2. Peptides corresponding to aa 28-45 and aa 239-258.
Database link: Q9Y4K0 -
Positive control
- WB: Non-transfected U87 MG cell lysate. Lysate from non-specific scrambled siRNA transfected cells. Cobalt chloride treated/ non-treated A549, MDA-MB-231, U87 MG and HeLa cell lysate. ICC: Cobalt chloride treated HeLa cells.
-
General notes
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains.
Recombinant multiclonal antibodies offer the sensitivity of polyclonal antibodies by recognising multiple epitopes, along with consistency of a recombinant antibody.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.4
Preservative: 0.09% Sodium azide
Constituent: 99.91% PBS -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Recombinant Multiclonal -
Clone number
7HCLC -
Isotype
IgG -
Research areas
Images
-
Knockdown of LOXL2 was achieved by transfecting U87MG cells with LOXL2 specific validated siRNA.
Western blot analysis was performed using modified whole cell extract (1% SDS) from the LOXL2 knock down cells (lane 3), non-specific scrambled siRNA transfected cells (lane 2) and nontransfected cells (lane 1).
The blots were probed with ab277807 at 1-3 μg/mL and a Goat anti-Rabbit IgG (H+L)-HRP secondary antibody (0.4 μg/mL, 1/2500 dilution).
Loss of signal upon siRNA mediated knock down confirms that antibody is specific to LOXL2.
-
For immunofluorescence analysis, HeLa cells were fixed and permeabilized for detection of endogenous LOXL2 using ab277807 at 5 μg/mL and labeled with Goat anti-Rabbit IgG (H+L) secondary antibody, Alexa Fluor® 488 conjugate (1/2000). Nuclei (blue) is stained with DAPI and cytoskeletal F-actin (red) staining using Rhodamine Phalloidin (1/300).
Panel a-d) Shows representative un-treated cells that were stained for detection and localization of LOXL2 protein (green) with less signal.
Panel e-h) Demonstrate enhanced perinuclear localisation of LOXL2 in cells treated with Cobalt chloride (100M 16h).
The images were captured at 60X magnification.
-
Western blot analysis was performed on whole cell extracts (30 μg lysate) of HeLa (human epithelial cell line from cervix adenocarcinoma) (Lane 1), HeLa treated with cobalt chloride (100 M for 16 hrs) (Lane 2), U-87 MG (human glioblastoma-astrocytoma epithelial cell line) (Lane 3), U-87 MG treated with cobalt chloride (100 M for 16 hrs) (Lane 4), MDA-MB-231 (human breast adenocarcinoma cell line) (Lane 5), MDA-MB-231 treated with cobalt chloride (100 M for 16 hrs) (Lane 6), A549 (human lung carcinoma cell line) (Lane 7) and A549 treated with cobalt chloride (100 M for 16 hrs) (Lane 8).
The blots were probed with Anti-LOXL2 Recombinant Rabbit Multiclonal Antibody (ab277807, 2.5 μg/mL) and detected by chemiluminescence using a Goat anti-Rabbit IgG (H+L)-HRP secondary antibody, (0.4 μg/mL, 1/4000 dilution). A 87 kDa band corresponding to LOXL2 was observed across the cell lines tested.
4-12% Bis-Tris gel.
The membrane was probed with the relevant primary and secondary antibody following blocking with 5% skimmed milk.
Chemiluminescent detection was ECL.
-